Evidence map›Paper›PMID 30455401›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

DRB4*01:01 Has a Distinct Motif and Presents a Proinsulin Epitope That Is Recognized in Subjects with Type 1 Diabetes.

Eddie A James, Laurel Gillette, Ivana Durinovic-Bello, Cate Speake, George P Bondinas, Antonis K Moustakas, Carla J Greenbaum, George K Papadopoulos, William W Kwok

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. PINK1 is a target of T cell responses in Parkinson's disease.bioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Eddie A JamesBenaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0002-7217-5729
Laurel GilletteBenaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0001-8993-6881
Ivana Durinovic-BelloBenaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0002-8828-3257
Cate SpeakeBenaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0003-1480-4272
George P BondinasLaboratory of Biophysics, Biochemistry, Bioprocessing and Bioproducts, Faculty of Agricultural Technology, Technological Educational Institute of Epirus, GR47100 Arta, Greece.ORCID 0000-0003-0699-2664
Antonis K MoustakasDepartment of Food Technology, Technological Educational Institute of Ionian Islands, GR27100 Argostoli, Cephalonia, Greece; and.
Carla J GreenbaumBenaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0003-4451-9800
George K PapadopoulosLaboratory of Biophysics, Biochemistry, Bioprocessing and Bioproducts, Faculty of Agricultural Technology, Technological Educational Institute of Epirus, GR47100 Arta, Greece.
William W KwokBenaroya Research Institute at Virginia Mason, Seattle, WA 98101; bkwok@benaroyaresearch.org.
Virginia Mason Medical Center · USTechnological Educational Institute of Epirus · GRTechnological Educational Institute of the Ionian Islands · GR

Funding

NIAID NIH HHS HHSN266200400028C
6 · The paper itself

Abstract

DRB4*01:01 (DRB4) is a secondary HLA-DR product that is part of the high-risk DR4/DQ8 haplotype that is associated with type 1 diabetes (T1D). DRB4 shares considerable homology with HLA-DR4 alleles that predispose to autoimmunity, including DRB1*04:01 and DRB1*04:04. However, the DRB4 protein sequence includes distinct residues that would be expected to alter the characteristics of its binding pockets. To identify high-affinity peptides that are recognized in the context of DRB4, we used an HLA class II tetramer-based approach to identify epitopes within multiple viral Ags. We applied a similar approach to identify antigenic sequences within glutamic acid decarboxylase 65 and pre-proinsulin that are recognized in the context of DRB4. Seven sequences were immunogenic, eliciting high-affinity T cell responses in DRB4

Indexed as

Amino Acid MotifsAntigen PresentationAutoantigensDiabetes Mellitus, Type 1Epitope MappingEpitopes, T-LymphocyteGenetic Predisposition to DiseaseGlutamate DecarboxylaseHLA-DRB1 ChainsHumansLymphocyte ActivationModels, ChemicalPeptidesProinsulinT-LymphocytesAutoantigensEpitopes, T-LymphocyteGlutamate Decarboxylaseglutamate decarboxylase 2HLA-DRB1 ChainsHLA-DRB4*01:01 antigenPeptidesProinsulin

Identifiers

PMID30455401
PMCPMC6426329
OpenAlexW2901066521

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.